<?properties open_access?>
<?subarticle report53217?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">F1000Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">F1000Res</journal-id>
    <journal-id journal-id-type="pmc">F1000Research</journal-id>
    <journal-title-group>
      <journal-title>F1000Research</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2046-1402</issn>
    <publisher>
      <publisher-name>F1000 Research Limited</publisher-name>
      <publisher-loc>London, UK</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6749933</article-id>
    <article-id pub-id-type="doi">10.12688/f1000research.18048.2</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Data Note</subject>
      </subj-group>
      <subj-group>
        <subject>Articles</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>A curated transcriptome dataset collection to investigate inborn errors of immunity</article-title>
      <fn-group content-type="pub-status">
        <fn>
          <p>[version 2; peer review: 2 approved]</p>
        </fn>
      </fn-group>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Bougarn</surname>
          <given-names>Salim</given-names>
        </name>
        <role content-type="http://credit.casrai.org/">Conceptualization</role>
        <role content-type="http://credit.casrai.org/">Data Curation</role>
        <role content-type="http://credit.casrai.org/">Formal Analysis</role>
        <role content-type="http://credit.casrai.org/">Investigation</role>
        <role content-type="http://credit.casrai.org/">Resources</role>
        <role content-type="http://credit.casrai.org/">Software</role>
        <role content-type="http://credit.casrai.org/">Validation</role>
        <role content-type="http://credit.casrai.org/">Visualization</role>
        <role content-type="http://credit.casrai.org/">Writing – Original Draft Preparation</role>
        <role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
        <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1132-6615</contrib-id>
        <xref ref-type="corresp" rid="c1">a</xref>
        <xref ref-type="aff" rid="a1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Boughorbel</surname>
          <given-names>Sabri</given-names>
        </name>
        <role content-type="http://credit.casrai.org/">Data Curation</role>
        <role content-type="http://credit.casrai.org/">Resources</role>
        <role content-type="http://credit.casrai.org/">Software</role>
        <role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
        <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2734-3356</contrib-id>
        <xref ref-type="aff" rid="a1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Chaussabel</surname>
          <given-names>Damien</given-names>
        </name>
        <role content-type="http://credit.casrai.org/">Conceptualization</role>
        <role content-type="http://credit.casrai.org/">Funding Acquisition</role>
        <role content-type="http://credit.casrai.org/">Project Administration</role>
        <role content-type="http://credit.casrai.org/">Supervision</role>
        <role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
        <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7287-1636</contrib-id>
        <xref ref-type="aff" rid="a1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Marr</surname>
          <given-names>Nico</given-names>
        </name>
        <role content-type="http://credit.casrai.org/">Conceptualization</role>
        <role content-type="http://credit.casrai.org/">Project Administration</role>
        <role content-type="http://credit.casrai.org/">Supervision</role>
        <role content-type="http://credit.casrai.org/">Writing – Review &amp; Editing</role>
        <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1927-7072</contrib-id>
        <xref ref-type="aff" rid="a1">1</xref>
      </contrib>
      <aff id="a1"><label>1</label>Systems Biology and Immunology, Sidra Medicine, Doha, Qatar</aff>
    </contrib-group>
    <author-notes>
      <corresp id="c1">
        <label>a</label>
        <email xlink:href="mailto:sbougarn@sidra.org">sbougarn@sidra.org</email>
      </corresp>
      <fn fn-type="COI-statement">
        <p>No competing interests were disclosed.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="epub">
      <day>30</day>
      <month>8</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2019</year>
    </pub-date>
    <volume>8</volume>
    <elocation-id>188</elocation-id>
    <history>
      <date date-type="accepted">
        <day>28</day>
        <month>8</month>
        <year>2019</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Copyright: © 2019 Bougarn S et al.</copyright-statement>
      <copyright-year>2019</copyright-year>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:href="f1000research-8-22465.pdf"/>
    <abstract>
      <p>Primary immunodeficiencies (PIDs) are a heterogeneous group of inherited disorders, frequently caused by loss-of-function and less commonly by gain-of-function mutations, which can result in susceptibility to a broad or a very narrow range of infections but also in inflammatory, allergic or malignant diseases. Owing to the wide range in clinical manifestations and variability in penetrance and expressivity, there is an urgent need to better understand the underlying molecular, cellular and immunological phenotypes in PID patients in order to improve clinical diagnosis and management. Here we have compiled a manually curated collection of public transcriptome datasets mainly obtained from human whole blood, peripheral blood mononuclear cells (PBMCs) or fibroblasts of patients with PIDs and of control subjects for subsequent meta-analysis, query and interpretation. A total of eighteen (18) datasets derived from studies of PID patients were identified and retrieved from the NCBI Gene Expression Omnibus (GEO) database and loaded in GXB, a custom web application designed for interactive query and visualization of integrated large-scale data. The dataset collection includes samples from well characterized PID patients that were stimulated
<italic>ex vivo</italic> under a variety of conditions to assess the molecular consequences of the underlying, naturally occurring gene defects on a genome-wide scale. Multiple sample groupings and rank lists were generated to facilitate comparisons of the transcriptional responses between different PID patients and control subjects. The GXB tool enables browsing of a single transcript across studies, thereby providing new perspectives on the role of a given molecule across biological systems and PID patients. This dataset collection is available at
<ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/list">http://pid.gxbsidra.org/dm3/geneBrowser/list</ext-link>.</p>
    </abstract>
    <kwd-group kwd-group-type="author">
      <kwd>Transcriptomics</kwd>
      <kwd>microarray</kwd>
      <kwd>primary immunodeficiency disorders</kwd>
      <kwd>inborn errors of immunity.</kwd>
    </kwd-group>
    <funding-group>
      <award-group id="fund-1" xlink:href="http://dx.doi.org/10.13039/100007458">
        <funding-source>Qatar Foundation</funding-source>
      </award-group>
      <award-group id="fund-2" xlink:href="http://dx.doi.org/10.13039/100008982">
        <funding-source>Qatar National Research Fund</funding-source>
        <award-id>NPRP10-0205-170348</award-id>
      </award-group>
      <funding-statement>All the authors listed on this publication received support from the Qatar Foundation. Support for this project was provided by the Qatar National Research Fund award NPRP10-0205-170348. </funding-statement>
      <funding-statement>
        <italic>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</italic>
      </funding-statement>
    </funding-group>
  </article-meta>
  <notes notes-type="version-changes">
    <sec sec-type="version-changes">
      <label>Revised</label>
      <title>Amendments from Version 1</title>
      <p>In this new version, I took in consideration very helpful reviewers comments and did some minor changes. The tutorials link on how to use the tools was updated. also, the GSE29536 datasets was removed from the instance and the datanote (table 1). Finally, the figure 1 was modified.</p>
    </sec>
  </notes>
</front>
<body>
  <sec sec-type="intro">
    <title>Introduction</title>
    <p>Primary immunodeficiencies (PIDs) are a heterogeneous group of inherited disorders, most often caused by loss-of-function mutations and less commonly by gain-of-function mutations, affecting components of the innate and/or adaptive immune system
<sup><xref rid="ref-1" ref-type="bibr">1</xref>–
<xref rid="ref-3" ref-type="bibr">3</xref></sup>. These inborn errors of immunity can result in profoundly increased susceptibility to a broad or a very narrow range of infections but also autoimmune disorders, allergies and malignancies
<sup><xref rid="ref-1" ref-type="bibr">1</xref>,
<xref rid="ref-4" ref-type="bibr">4</xref>–
<xref rid="ref-6" ref-type="bibr">6</xref></sup>. The spectrum of clinical manifestations of PIDs is very broad and largely dependent upon the affected gene(s) and the degree to which normal gene function is lost or altered. In addition, a variety of other factors such as germline or somatic mosaicism, modifier genes and environmental factors can play an important role in the clinical penetrance and expressivity of a given disease phenotype
<sup><xref rid="ref-3" ref-type="bibr">3</xref>,
<xref rid="ref-7" ref-type="bibr">7</xref>,
<xref rid="ref-8" ref-type="bibr">8</xref></sup>. To date, mutations in more than 300 genes have been identified to cause PIDs, which are classified into major groups reflecting the diverse immunological phenotypes
<sup><xref rid="ref-5" ref-type="bibr">5</xref>,
<xref rid="ref-9" ref-type="bibr">9</xref></sup>. Nonetheless, PIDs often go unrecognized or are not properly diagnosed
<sup><xref rid="ref-10" ref-type="bibr">10</xref></sup>. However, with the recent developments and rapidly declining costs of next-generation sequencing technologies and other high-throughput methods, it is expected that many more as yet unknown disease-related genetic variants will be discovered in the near future
<sup><xref rid="ref-7" ref-type="bibr">7</xref></sup>.</p>
    <p>A considerable challenge for identifying causal genetic variants—which is critical for the diagnosis and clinical management of PID patients—lies in the vast heterogeneity of the underlying immunological phenotypes and clinical manifestations on the one hand and in the degree of human genetic variation between individuals on the other hand. Despite considerable advances in recent years, specific gene functions in humans, their roles and regulation in biological processes, and essentiality of the redundancy in a function of a particular gene for protective immunity of the human host remains poorly understood
<sup><xref rid="ref-6" ref-type="bibr">6</xref></sup>. In many cases, the use of forward and reverse genetics in mice or other model organisms has provided insufficient insights into the pathophysiology of PIDs, this due to interspecies differences and the fact that inbreeding has let to various deficiencies in laboratory animals, rendering them susceptible to a broad range of infections that often poorly recapitulates the clinical phenotypes in humans
<sup><xref rid="ref-11" ref-type="bibr">11</xref></sup>. On the other hand, studying naturally occurring genetic defects in humans is much more challenging given the difficulty of obtaining biological samples, ethical implications and potential risks that go along with it. An additional challenge is the low frequency of most null alleles. Although PIDs are not necessarily rare when considered collectively, the small number of individuals that suffer from a specific deficiency usually does not permit classic case-control or family-based genetic association studies. Indeed, a considerable proportion of monogenic etiologies of PIDs were initially reported in single patients
<sup><xref rid="ref-12" ref-type="bibr">12</xref></sup>. The ability to identify single-gene inborn errors in PID patients requires validation of the disease-causing variant by in-depth mechanistic studies demonstrating the structural and functional consequences of the mutations using blood or other accessible biological samples such as fibroblasts from skin biopsies
<sup><xref rid="ref-12" ref-type="bibr">12</xref></sup>. In this context, several transcriptomics studies have been conducted using whole blood, PBMCs and fibroblasts of well-characterized PID patients, to assess the underlying immunological phenotypes at the molecular and cellular levels in more detail (
<xref rid="T1" ref-type="table">Table 1</xref>) and in many cases, to further validate the causal relationship between the underlying genotypes and clinical phenotypes. Notable are several seminal studies of PID patients with susceptibility to a very narrow range of pathogens, such as patients with MYD88 or IRAK4 deficiency who are primarily susceptible to pyrogenic bacterial infections
<sup><xref rid="ref-13" ref-type="bibr">13</xref>,
<xref rid="ref-14" ref-type="bibr">14</xref></sup>, patients with TBK1, TRIF or TLR3 deficiency
<sup><xref rid="ref-15" ref-type="bibr">15</xref>–
<xref rid="ref-17" ref-type="bibr">17</xref></sup> which underlies herpes simplex encephalitis of childhood, or a recent study of a child with IRF7 deficiency who was primarily susceptible to severe influenza but otherwise immunocompetent with regard to other common infectious diseases
<sup><xref rid="ref-18" ref-type="bibr">18</xref></sup>. Such studies have highlighted that often, the underlying gene defect may only affect a narrow repertoire of transcriptional responses while the affected individual's cells remain highly responsive to specific stimulation through alternate receptors, pathways and signaling networks and in particular to
<italic>ex vivo</italic> stimulation with whole organisms, reflecting the high degree of human gene redundancy in host defenses
<sup><xref rid="ref-6" ref-type="bibr">6</xref></sup>.</p>
    <table-wrap id="T1" orientation="portrait" position="anchor">
      <label>Table 1. </label>
      <caption>
        <title>List of datasets constituting the collection.</title>
      </caption>
      <table frame="hsides" rules="groups" content-type="article-table">
        <thead>
          <tr>
            <th align="center" valign="middle" rowspan="1" colspan="1">Title</th>
            <th align="center" valign="middle" rowspan="1" colspan="1">Platforms used</th>
            <th align="center" valign="middle" rowspan="1" colspan="1">PID classification</th>
            <th align="center" valign="middle" rowspan="1" colspan="1">Disease</th>
            <th align="center" valign="middle" rowspan="1" colspan="1">Genetic defects</th>
            <th align="center" valign="middle" rowspan="1" colspan="1">Cell type/
<break/>Tissues</th>
            <th align="center" valign="middle" rowspan="1" colspan="1">Number
<break/>of
<break/>samples</th>
            <th align="center" valign="middle" rowspan="1" colspan="1">Citation #</th>
            <th align="center" valign="middle" rowspan="1" colspan="1">GEO ID</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000039">Complete TLR3 deficiency. GSE30951.</ext-link>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Illumina
<break/>HumanHT-12 v4</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Defects in intrinsic
<break/>and innate immunity</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">MyD88,
<break/>TLR3,
<break/>UNC93B1
<break/>deficiencies</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Mutations of
<break/>
<italic>MyD88</italic>,
<italic>TLR3,</italic>
<break/>and
<italic>UNC93B1</italic>
</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Fibroblast/
<break/>PBMC</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">44</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <xref rid="ref-17" ref-type="bibr">17</xref>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE30951">GSE30951</ext-link>
            </td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000031">Genome-wide profiling of whole blood from patients</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000031">with defects in Toll-like receptors (TLRs) and IL-1Rs</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000031">(the TIR pathway) signaling.</ext-link>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Illumina
<break/>HumanHT-12 v4</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Defects in intrinsic
<break/>and innate immunity</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">IRAK4,
<break/>MyD88
<break/>deficiencies</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Mutations of
<break/>
<italic>IRAK4</italic>, and
<break/>
<italic>MyD88</italic>
</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Whole blood</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">365</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <xref rid="ref-14" ref-type="bibr">14</xref>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE25742">GSE25742</ext-link>
            </td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000044">Identification of IL-21-induced STAT3 dependent</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000044">genes in human B cells.</ext-link>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Affymetrix
<break/>HuGene 1.0
<break/>ST v1</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Diseases of immune
<break/>dysregulation</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">STAT3 GOF
<break/>mutations</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Mutations in
<break/>
<italic>STAT3</italic>
</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">B cells</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">14</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <xref rid="ref-20" ref-type="bibr">20</xref>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51587">GSE51587</ext-link>
            </td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000033">Impaired intrinsic immunity to HSV-1 in human iPSC-</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000033">derived TLR3-deficient CNS cells.</ext-link>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Illumina
<break/>HumanWG-6 v3</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Defects in intrinsic
<break/>and innate immunity</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">UNC93B1
<break/>deficiency</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Mutations of
<break/>
<italic>UNC93B1</italic>
</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">iPS</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">18</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <xref rid="ref-21" ref-type="bibr">21</xref>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE40593">GSE40593</ext-link>
            </td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000027">In vitro response of fibroblasts isolated from patients</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000027">with immunodeficiencies.</ext-link>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Illumina Human-
<break/>6 v2</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Defects in intrinsic
<break/>and innate immunity
<break/>
<break/>Combined
<break/>immunodeficiencies
<break/>with associated or
<break/>syndromic features</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">UNC93B1,
<break/>MyD88,
<break/>IRAK4,
<break/>STAT1,
<break/>NEMO
<break/>deficiencies</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Mutations of
<break/>
<italic>UNC93B1</italic>,
<break/>
<italic>MyD88</italic>,
<italic>IRAK4</italic>,
<break/>
<italic>STAT1,</italic> and
<break/>
<italic>NEMO</italic>
</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Fibroblast</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">72</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <xref rid="ref-13" ref-type="bibr">13</xref>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE12124">GSE12124</ext-link>
            </td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000032">In vitro response of fibroblasts isolated from patients</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000032">with RBCK1 deficiency.</ext-link>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Illumina
<break/>HumanHT-12 v4</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Defects in intrinsic
<break/>and innate immunity
<break/>
<break/>Combined
<break/>immunodeficiencies
<break/>with associated or
<break/>syndromic features</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">MyD88,
<break/>HOIL1,
<break/>NEMO
<break/>deficiencies</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Mutations of
<break/>
<italic>MyD88</italic>,
<italic>HOIL1</italic>/
<break/>
<italic>RBCK1,</italic> and
<break/>
<italic>NEMO</italic>
</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Fibroblast</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">46</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <xref rid="ref-22" ref-type="bibr">22</xref>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31064">GSE31064</ext-link>
            </td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000038">In vitro responses of fibroblasts from patients</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000038">with TBK1 deficiency after TLR3 dependent and</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000038">independent stimuli.</ext-link>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Illumina
<break/>HumanHT-12 v4</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Defects in intrinsic
<break/>and innate immunity</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">TLR3, TBK1,
<break/>STAT1
<break/>deficiencies</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Mutations of
<break/>
<italic>TLR3</italic>,
<italic>TBK1,</italic> and
<break/>
<italic>STAT1</italic>
</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Fibroblast</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">58</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <xref rid="ref-15" ref-type="bibr">15</xref>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE38652">GSE38652</ext-link>
            </td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000030">In vitro responses of PBMC and fibroblasts from</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000030">patients with TRIF deficiency after TRIF dependent</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000030">and independent stimuli.</ext-link>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Illumina
<break/>HumanHT-12 v4</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Defects in intrinsic
<break/>and innate immunity</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">TLR3, TRIF
<break/>and MyD88
<break/>deficiencies</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Mutations of
<break/>
<italic>TLR3</italic>,
<italic>TRIF,</italic> and
<break/>
<italic>MyD88</italic>
</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Fibroblast,
<break/>PBMC</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">27</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <xref rid="ref-16" ref-type="bibr">16</xref>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32390">GSE32390</ext-link>
            </td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000046">Increased Wnt and Notch signaling: A clue to</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000046">the renal disease in Schimke immuno-osseous</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000046">dysplasia?.</ext-link>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Affymetrix HG-
<break/>U133_Plus_2</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Combined
<break/>immunodeficiencies
<break/>with associated or
<break/>syndromic features</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Schimke
<break/>immuno-
<break/>osseous
<break/>dysplasia
<break/>(SIOD)</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Mutations in
<break/>
<italic>SMARCAL1</italic>
</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Kidney biopsy</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">5</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <xref rid="ref-23" ref-type="bibr">23</xref>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE81156">GSE81156</ext-link>
            </td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000045">Inherited human IRAK-1 deficiency selectively</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000045">abolishes TLR signaling in fibroblasts.</ext-link>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Illumina
<break/>HumanHT-12 v4</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Defects in intrinsic
<break/>and innate immunity</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">IRAK4,
<break/>MyD88
<break/>deficiencies</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Mutations of
<break/>
<italic>IRAK1</italic>,
<italic>IRAK4</italic>,
<break/>
<italic>MyD88,</italic> and
<break/>
<italic>MECP2</italic>
</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Fibroblast</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">64</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <xref rid="ref-24" ref-type="bibr">24</xref>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92466">GSE92466</ext-link>
            </td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000043">Interferon Signature in the Blood in Inflammatory</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000043">Common Variable Immune Deficiency [Test Set].</ext-link>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Illumina
<break/>HumanHT-12 v4</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Predominantly
<break/>antibody deficiencies</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Common
<break/>Variable
<break/>Immune
<break/>Deficiency
<break/>(CVID)</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Whole blood</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">53</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <xref rid="ref-25" ref-type="bibr">25</xref>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51404">GSE51404</ext-link>
            </td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000042">Interferon Signature in the Blood in Inflammatory</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000042">Common Variable Immune Deficiency [Training Set].</ext-link>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Illumina
<break/>HumanHT-12 v3</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Predominantly
<break/>antibody deficiencies</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Common
<break/>Variable
<break/>Immune
<break/>Deficiency
<break/>(CVID)</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Whole blood</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">83</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <xref rid="ref-25" ref-type="bibr">25</xref>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51405">GSE51405</ext-link>
            </td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000040">IRAK-4- and MyD88-dependent pathways are</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000040">essential for the removal of developing autoreactive B</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000040">cells in humans.</ext-link>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Affymetrix HG-
<break/>U133_Plus_2</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Defects in intrinsic
<break/>and innate immunity</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">UNC93B1,
<break/>MyD88,
<break/>and IRAK4
<break/>deficiencies</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Mutations of
<break/>
<italic>UNC93B1</italic>,
<break/>
<italic>MyD88</italic>, and
<break/>
<italic>IRAK4</italic>
</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">B cells</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">5</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <xref rid="ref-26" ref-type="bibr">26</xref>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE13300">GSE13300</ext-link>
            </td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000034">Response of IRF7-deficient peripheral blood</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000034">mononuclear cells to pH1N1 influenza virus infection.</ext-link>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Illumina
<break/>HumanHT-12 v4</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Defects in intrinsic
<break/>and innate immunity</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">UNC93B1,
<break/>and IRF7
<break/>deficiencies</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Mutations of
<break/>
<italic>UNC93B1</italic>, and
<break/>
<italic>IRF7</italic>
</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">PBMC</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">18</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <xref rid="ref-18" ref-type="bibr">18</xref>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE66486">GSE66486</ext-link>
            </td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000028">Screening for differentially expressed genes in</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000028">patients with a novel immunodeficiency syndrome.</ext-link>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Affymetrix HG-
<break/>U133A</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Congenital defects of
<break/>phagocyte number,
<break/>functions, or both</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">p14/
<break/>LAMTOR2
<break/>deficiency</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Mutations
<break/>in
<italic>ROBLD3</italic>/
<break/>
<italic>LAMTOR2</italic>
</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">B cells</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">4</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <xref rid="ref-27" ref-type="bibr">27</xref>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE6322">GSE6322</ext-link>
            </td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000036">Transcriptional analysis of whole blood in patients</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000036">with auto-inflammatory disorders.</ext-link>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Illumina
<break/>HumanHT-12 v3</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Defects in intrinsic
<break/>and innate immunity
<break/>
<break/>Autoinflammatory
<break/>disorders</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">UNC93B1,
<break/>MyD88,
<break/>and IRAK4
<break/>deficiencies
<break/>
<break/>Defects
<break/>affecting the
<break/>inflammsome</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Mutations of
<break/>
<italic>UNC93B1</italic>,
<break/>
<italic>MyD88</italic>, and
<break/>
<italic>IRAK4, NLRP3,</italic>
<break/>
<italic>MVK</italic>
</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Whole blood</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">51</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <xref rid="ref-22" ref-type="bibr">22</xref>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE40561">GSE40561</ext-link>
            </td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000035">Transcriptome analysis in peripheral blood</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000035">mononuclear cells (PBMC) from HOIL-1-deficient</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000035">patients upon TNF-a or IL-1b stimulation.</ext-link>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Illumina
<break/>HumanHT-12 v4</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Combined
<break/>immunodeficiencies
<break/>with associated or
<break/>syndromic features</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">HOLI1
<break/>deficiency</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Mutations of
<break/>
<italic>HOLI1/RBCK1</italic>
</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">PBMC</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">45</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <xref rid="ref-22" ref-type="bibr">22</xref>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE40838">GSE40838</ext-link>
            </td>
          </tr>
          <tr>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000037">Transcriptome analysis in primary fibroblasts from</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000037">HOIL-1-deficient patients upon TNF-a or IL-1b</ext-link>
              <break/>
              <ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000037">stimulation.</ext-link>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Illumina
<break/>HumanHT-12 v4</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Defects in intrinsic
<break/>and innate immunity
<break/>
<break/>Combined
<break/>immunodeficiencies
<break/>with associated or
<break/>syndromic features</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">MyD88,
<break/>HOIL1,
<break/>NEMO
<break/>deficiencies</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Mutations of
<break/>
<italic>MyD88</italic>,
<italic>HOIL1</italic>/
<break/>
<italic>RBCK1,</italic> and
<break/>
<italic>NEMO</italic>
</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">Fibroblast</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">54</td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <xref rid="ref-22" ref-type="bibr">22</xref>
            </td>
            <td align="center" valign="middle" rowspan="1" colspan="1">
              <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE40560">GSE40560</ext-link>
            </td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <p>Here, we compiled a curated collection of 18 transcriptome datasets, retrieved from the NCBI's Gene Expression Omnibus (GEO) database, to provide as resource for the investigation on inborn errors of immunity. The datasets were loaded into a custom interactive web application, the Gene Expression Browser (GXB), (
<ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/list">http://pid.gxbsidra.org/dm3/geneBrowser/list</ext-link>), which allows seamless access to the data and interactive visualization of the transcriptional responses, along with demographic and clinical information
<sup><xref rid="ref-19" ref-type="bibr">19</xref></sup>. The user can customize data plots by adding multiple layers of parameters (e.g. age, gender, sample type and type of genetic defects), select and modify the sample ordering and gene rank lists, and generate links (mini URL) that can be shared via e-mail or used in publications. The GXB tool enables browsing of a single transcript across multiple studies and datasets, providing new perspectives on the role of a given molecule across biological systems and PID patients. In summary, this dataset collection can aid clinicians and researchers to study and quickly visualize the functional consequences of a variety of well characterized, naturally occurring mutations on a genome-wide scale.</p>
  </sec>
  <sec sec-type="methods">
    <title>Methods</title>
    <p>A total of 163 datasets were identified in GEO using the following search query: Homo sapiens AND (“primary immunodeficiency diseases” OR “primary immunodeficiencies diseases” OR PID OR “autosomal recessive” OR “autosomal dominant” OR “inherited deficiency”) AND (“Expression profiling by array”). All GEO entries that were returned with this query were manually curated. This process involved reading all the descriptions available for the datasets, the study designs and corresponding research articles. Finally, a total of 18 datasets were retained because they contained samples which were obtained from well characterized patients with known PIDs (i.e. the genetic etiology had been identified) or the samples were obtained from patients which were considered to have common variable immunodeficiency (CVID). These include datasets that were generated from whole blood, PBMCs, fibroblasts, B cells, Induced Pluripotent Stem Cells (iPS) and kidney biopsy of individuals with defects in intrinsic and innate immunity, combined immunodeficiencies with associated or syndromic features, autoinflammatory disorders, congenital defects of phagocyte number, functions, or both, predominantly antibody deficiencies and diseases of immune dysregulation. However, In the future, this current instance might be updated by adding additional datasets. The selected datasets are listed in
<xref rid="T1" ref-type="table">Table 1</xref>. A breakdown of the dataset collection by category in accordance to the most recently published update on PID classification from International Union of Immunological Societies Expert Committee
<sup><xref rid="ref-5" ref-type="bibr">5</xref>,
<xref rid="ref-9" ref-type="bibr">9</xref></sup> is shown in
<xref ref-type="fig" rid="f1">Figure 1</xref>.</p>
    <fig fig-type="figure" id="f1" orientation="portrait" position="anchor">
      <label>Figure 1. </label>
      <caption>
        <title>Break down of the dataset collection by category.</title>
        <p>The pie chart indicates the PIDs classification out for the 18 datasets.</p>
      </caption>
      <graphic xlink:href="f1000research-8-22465-g0000"/>
    </fig>
    <p>The selected datasets were downloaded from GEO using the SOFT file format. Then, the datasets were uploaded onto our web tool, called the Gene Expression Browser (GXB), an interactive application hosted on the Amazon Web Services cloud
<sup><xref rid="ref-19" ref-type="bibr">19</xref></sup>. Information about samples and study design were also uploaded. The available samples were assigned to groups based on the individuals and deficiencies studied and genes were ranked according to different group comparisons allowing the identification of transcripts that were differentially expressed between the patient's and control subject's cells cultured or stimulated
<italic>ex vivo</italic> under the same conditions. Our dataset collection, uploaded in GXB, is available at
<ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/list">http://pid.gxbsidra.org/dm3/geneBrowser/list</ext-link>. A web tutorial for the use of GXB can be accessed at:
<ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/tutorials.gsp">http://pid.gxbsidra.org/dm3/tutorials.gsp</ext-link>.</p>
    <p>A detailed description of GXB has been recently published
<sup><xref rid="ref-19" ref-type="bibr">19</xref>,
<xref rid="ref-28" ref-type="bibr">28</xref>–
<xref rid="ref-30" ref-type="bibr">30</xref></sup> and is reproduced here so that readers can use this article as a standalone resource. Briefly, datasets of interest can be quickly identified either by filtering on criteria from pre-defined sections on the left or by entering a query term in the search box at the top of the dataset navigation page. Clicking on one of the studies listed in the dataset navigation page opens a viewer designed to provide interactive browsing and graphic representations of large-scale data in an interpretable format. This interface is designed to present ranked gene lists and display expression results graphically in a context-rich environment. Selecting a gene from the rank ordered list on the left of the data-viewing interface will display its expression values graphically in the screen’s central panel. Directly above the graphical display drop down menus give users the ability: a) To change how the gene list is ranked - this allows the user to change the method used to rank the genes, or to only include genes that are selected for specific biological interest; b) To change sample grouping (Group Set button) - in some datasets, a user can switch between groups based on cell type to groups based on disease type, for example; c) To sort individual samples within a group based on associated categorical or continuous variables (e.g. gender or age); d) To toggle between the bar chart view and a box plot view, with expression values represented as a single point for each sample. Samples are split into the same groups whether displayed as a bar chart or box plot; e) To provide a color legend for the sample groups; f) To select categorical information that is to be overlaid at the bottom of the graph - for example, the user can display gender or smoking status in this manner; g) To provide a color legend for the categorical information overlaid at the bottom of the graph; h) To download the graph as a portable network graphics (png) image. Measurements have no intrinsic utility in absence of contextual information. It is this contextual information that makes the results of a study or experiment interpretable. It is therefore important to capture, integrate and display information that will give users the ability to interpret data and gain new insights from it. We have organized this information under different tabs directly above the graphical display. The tabs can be hidden to make more room for displaying the data plots, or revealed by clicking on the blue “show info panel” button on the top right corner of the display. Information about the gene selected from the list on the left side of the display is available under the “Gene” tab. Information about the study is available under the “Study” tab. Rolling the mouse cursor over a bar chart feature while displaying the “Sample” tab lists any clinical, demographic, or laboratory information available for the selected sample. Finally, the “Downloads” tab allows advanced users to retrieve the original dataset for analysis outside this tool. It also provides all available sample annotation data for use alongside the expression data in third party analysis software. Other functionalities are provided under the “Tools” drop-down menu located in the top right corner of the user interface. Some of the notable functionalities available through this menu include: a) Annotations, which provides access to all the ancillary information about the study, samples and dataset organized across different tabs; b) Cross-project view; which provides the ability for a given gene to browse through all available studies; c) Copy link, which generates a mini-URL encapsulating information about the display settings in use and that can be saved and shared with others (clicking on the envelope icon on the toolbar inserts the URL in an email message via the local email client); d) Chart options; which gives user the option to customize chart labels.</p>
  </sec>
  <sec sec-type="data-availability">
    <title>Data availability</title>
    <p>All datasets included in our curated collection are available publicly via the NCBI GEO website:
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/gds/">https://www.ncbi.nlm.nih.gov/gds/</ext-link> and are referenced throughout the manuscript by their GEO accession numbers (e.g.
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92466">GSE92466</ext-link>). Signal files and sample description files can also be downloaded from the GXB tool under the “downloads” tab.</p>
  </sec>
</body>
<back>
  <ack>
    <title>Acknowledgments</title>
    <p>We would like to thank all the investigators who decided to make their datasets publicly available by depositing them in GEO.</p>
  </ack>
  <ref-list>
    <ref id="ref-1">
      <label>1</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seleman</surname><given-names>M</given-names></name><name><surname>Hoyos-Bachiloglu</surname><given-names>R</given-names></name><name><surname>Geha</surname><given-names>RS</given-names></name><etal/></person-group>:
<article-title>Uses of Next-Generation Sequencing Technologies for the Diagnosis of Primary Immunodeficiencies.</article-title><source><italic toggle="yes">Front Immunol.</italic></source><year>2017</year>;<volume>8</volume>:<fpage>847</fpage>.
<pub-id pub-id-type="doi">10.3389/fimmu.2017.00847</pub-id><!--<pub-id pub-id-type="pmcid">5522848</pub-id>--><?supplied-pmid 28791010?><pub-id pub-id-type="pmid">28791010</pub-id></mixed-citation>
    </ref>
    <ref id="ref-2">
      <label>2</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casanova</surname><given-names>JL</given-names></name></person-group>:
<article-title>Human genetic basis of interindividual variability in the course of infection.</article-title><source><italic toggle="yes">Proc Natl Acad Sci U S A.</italic></source><year>2015</year>;<volume>112</volume>(<issue>51</issue>):<fpage>E7118</fpage>–<lpage>27</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1521644112</pub-id><!--<pub-id pub-id-type="pmcid">4697415</pub-id>--><?supplied-pmid 26621739?><pub-id pub-id-type="pmid">26621739</pub-id></mixed-citation>
    </ref>
    <ref id="ref-3">
      <label>3</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casanova</surname><given-names>JL</given-names></name></person-group>:
<article-title>Severe infectious diseases of childhood as monogenic inborn errors of immunity.</article-title><source><italic toggle="yes">Proc Natl Acad Sci U S A.</italic></source><year>2015</year>;<volume>112</volume>(<issue>51</issue>):<fpage>E7128</fpage>–<lpage>37</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1521651112</pub-id><!--<pub-id pub-id-type="pmcid">4697435</pub-id>--><?supplied-pmid 26621750?><pub-id pub-id-type="pmid">26621750</pub-id></mixed-citation>
    </ref>
    <ref id="ref-4">
      <label>4</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allenspach</surname><given-names>E</given-names></name><name><surname>Torgerson</surname><given-names>TR</given-names></name></person-group>:
<article-title>Autoimmunity and Primary Immunodeficiency Disorders.</article-title><source><italic toggle="yes">J Clin Immunol.</italic></source><year>2016</year>;<volume>36</volume>(<issue>Suppl 1</issue>):<fpage>57</fpage>–<lpage>67</lpage>.
<pub-id pub-id-type="doi">10.1007/s10875-016-0294-1</pub-id><?supplied-pmid 27210535?><pub-id pub-id-type="pmid">27210535</pub-id></mixed-citation>
    </ref>
    <ref id="ref-5">
      <label>5</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picard</surname><given-names>C</given-names></name><name><surname>Al-Herz</surname><given-names>W</given-names></name><name><surname>Bousfiha</surname><given-names>A</given-names></name><etal/></person-group>:
<article-title>Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015.</article-title><source><italic toggle="yes">J Clin Immunol.</italic></source><year>2015</year>;<volume>35</volume>(<issue>8</issue>):<fpage>696</fpage>–<lpage>726</lpage>.
<pub-id pub-id-type="doi">10.1007/s10875-015-0201-1</pub-id><!--<pub-id pub-id-type="pmcid">4659841</pub-id>--><?supplied-pmid 26482257?><pub-id pub-id-type="pmid">26482257</pub-id></mixed-citation>
    </ref>
    <ref id="ref-6">
      <label>6</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casanova</surname><given-names>JL</given-names></name><name><surname>Abel</surname><given-names>L</given-names></name></person-group>:
<article-title>Human genetics of infectious diseases: Unique insights into immunological redundancy.</article-title><source><italic toggle="yes">Semin Immunol.</italic></source><year>2018</year>;<volume>36</volume>:<fpage>1</fpage>–<lpage>12</lpage>.
<pub-id pub-id-type="doi">10.1016/j.smim.2017.12.008</pub-id><!--<pub-id pub-id-type="pmcid">5910248</pub-id>--><?supplied-pmid 29254755?><pub-id pub-id-type="pmid">29254755</pub-id></mixed-citation>
    </ref>
    <ref id="ref-7">
      <label>7</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stray-Pedersen</surname><given-names>A</given-names></name><name><surname>Sorte</surname><given-names>HS</given-names></name><name><surname>Samarakoon</surname><given-names>P</given-names></name><etal/></person-group>:
<article-title>Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders.</article-title><source><italic toggle="yes">J Allergy Clin Immunol.</italic></source><year>2017</year>;<volume>139</volume>(<issue>1</issue>):<fpage>232</fpage>–<lpage>245</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jaci.2016.05.042</pub-id><!--<pub-id pub-id-type="pmcid">5222743</pub-id>--><?supplied-pmid 27577878?><pub-id pub-id-type="pmid">27577878</pub-id></mixed-citation>
    </ref>
    <ref id="ref-8">
      <label>8</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolach</surname><given-names>O</given-names></name><name><surname>Kuijpers</surname><given-names>T</given-names></name><name><surname>Ben-Ari</surname><given-names>J</given-names></name><etal/></person-group>:
<article-title>Variable clinical expressivity of STAT3 mutation in hyperimmunoglobulin E syndrome: genetic and clinical studies of six patients.</article-title><source><italic toggle="yes">J Clin Immunol.</italic></source><year>2014</year>;<volume>34</volume>(<issue>2</issue>):<fpage>163</fpage>–<lpage>70</lpage>.
<pub-id pub-id-type="doi">10.1007/s10875-014-9988-4</pub-id><?supplied-pmid 24452316?><pub-id pub-id-type="pmid">24452316</pub-id></mixed-citation>
    </ref>
    <ref id="ref-9">
      <label>9</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bousfiha</surname><given-names>A</given-names></name><name><surname>Jeddane</surname><given-names>L</given-names></name><name><surname>Picard</surname><given-names>C</given-names></name><etal/></person-group>:
<article-title>The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies.</article-title><source><italic toggle="yes">J Clin Immunol.</italic></source><year>2018</year>;<volume>38</volume>(<issue>1</issue>):<fpage>129</fpage>–<lpage>143</lpage>.
<pub-id pub-id-type="doi">10.1007/s10875-017-0465-8</pub-id><!--<pub-id pub-id-type="pmcid">5742599</pub-id>--><?supplied-pmid 29226301?><pub-id pub-id-type="pmid">29226301</pub-id></mixed-citation>
    </ref>
    <ref id="ref-10">
      <label>10</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>M</given-names></name><name><surname>Geng</surname><given-names>B</given-names></name><name><surname>Cameron</surname><given-names>DW</given-names></name><etal/></person-group>:
<article-title>Primary immune deficiency diseases as unrecognized causes of chronic respiratory disease.</article-title><source><italic toggle="yes">Respir Med.</italic></source><year>2017</year>;<volume>132</volume>:<fpage>181</fpage>–<lpage>188</lpage>.
<pub-id pub-id-type="doi">10.1016/j.rmed.2017.10.016</pub-id><?supplied-pmid 29229095?><pub-id pub-id-type="pmid">29229095</pub-id></mixed-citation>
    </ref>
    <ref id="ref-11">
      <label>11</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciancanelli</surname><given-names>MJ</given-names></name><name><surname>Abel</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>SY</given-names></name><etal/></person-group>:
<article-title>Host genetics of severe influenza: from mouse Mx1 to human IRF7.</article-title><source><italic toggle="yes">Curr Opin Immunol.</italic></source><year>2016</year>;<volume>38</volume>:<fpage>109</fpage>–<lpage>20</lpage>.
<pub-id pub-id-type="doi">10.1016/j.coi.2015.12.002</pub-id><!--<pub-id pub-id-type="pmcid">4733643</pub-id>--><?supplied-pmid 26761402?><pub-id pub-id-type="pmid">26761402</pub-id></mixed-citation>
    </ref>
    <ref id="ref-12">
      <label>12</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casanova</surname><given-names>JL</given-names></name><name><surname>Conley</surname><given-names>ME</given-names></name><name><surname>Seligman</surname><given-names>SJ</given-names></name><etal/></person-group>:
<article-title>Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies.</article-title><source><italic toggle="yes">J Exp Med.</italic></source><year>2014</year>;<volume>211</volume>(<issue>11</issue>):<fpage>2137</fpage>–<lpage>49</lpage>.
<pub-id pub-id-type="doi">10.1084/jem.20140520</pub-id><!--<pub-id pub-id-type="pmcid">4203950</pub-id>--><?supplied-pmid 25311508?><pub-id pub-id-type="pmid">25311508</pub-id></mixed-citation>
    </ref>
    <ref id="ref-13">
      <label>13</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Bernuth</surname><given-names>H</given-names></name><name><surname>Picard</surname><given-names>C</given-names></name><name><surname>Jin</surname><given-names>Z</given-names></name><etal/></person-group>:
<article-title>Pyogenic bacterial infections in humans with MyD88 deficiency.</article-title><source><italic toggle="yes">Science.</italic></source><year>2008</year>;<volume>321</volume>(<issue>5889</issue>):<fpage>691</fpage>–<lpage>696</lpage>.
<pub-id pub-id-type="doi">10.1126/science.1158298</pub-id><!--<pub-id pub-id-type="pmcid">2688396</pub-id>--><?supplied-pmid 18669862?><pub-id pub-id-type="pmid">18669862</pub-id></mixed-citation>
    </ref>
    <ref id="ref-14">
      <label>14</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsina</surname><given-names>L</given-names></name><name><surname>Israelsson</surname><given-names>E</given-names></name><name><surname>Altman</surname><given-names>MC</given-names></name><etal/></person-group>:
<article-title>A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in
<italic>MYD88</italic> or
<italic>IRAK4</italic>.</article-title><source><italic toggle="yes">Nat Immunol.</italic></source><year>2014</year>;<volume>15</volume>(<issue>12</issue>):<fpage>1134</fpage>–<lpage>42</lpage>.
<pub-id pub-id-type="doi">10.1038/ni.3028</pub-id><!--<pub-id pub-id-type="pmcid">4281021</pub-id>--><?supplied-pmid 25344726?><pub-id pub-id-type="pmid">25344726</pub-id></mixed-citation>
    </ref>
    <ref id="ref-15">
      <label>15</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herman</surname><given-names>M</given-names></name><name><surname>Ciancanelli</surname><given-names>M</given-names></name><name><surname>Ou</surname><given-names>YH</given-names></name><etal/></person-group>:
<article-title>Heterozygous
<italic>TBK1</italic> mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood.</article-title><source><italic toggle="yes">J Exp Med.</italic></source><year>2012</year>;<volume>209</volume>(<issue>9</issue>):<fpage>1567</fpage>–<lpage>1582</lpage>.
<pub-id pub-id-type="doi">10.1084/jem.20111316</pub-id><!--<pub-id pub-id-type="pmcid">3428952</pub-id>--><?supplied-pmid 22851595?><pub-id pub-id-type="pmid">22851595</pub-id></mixed-citation>
    </ref>
    <ref id="ref-16">
      <label>16</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sancho-Shimizu</surname><given-names>V</given-names></name><name><surname>Pérez de Diego</surname><given-names>R</given-names></name><name><surname>Lorenzo</surname><given-names>L</given-names></name><etal/></person-group>:
<article-title>Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency.</article-title><source><italic toggle="yes">J Clin Invest.</italic></source><year>2011</year>;<volume>121</volume>(<issue>12</issue>):<fpage>4889</fpage>–<lpage>902</lpage>.
<pub-id pub-id-type="doi">10.1172/JCI59259</pub-id><!--<pub-id pub-id-type="pmcid">3226004</pub-id>--><?supplied-pmid 22105173?><pub-id pub-id-type="pmid">22105173</pub-id></mixed-citation>
    </ref>
    <ref id="ref-17">
      <label>17</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>YQ</given-names></name><name><surname>Audry</surname><given-names>M</given-names></name><name><surname>Ciancanelli</surname><given-names>M</given-names></name><etal/></person-group>:
<article-title>Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity.</article-title><source><italic toggle="yes">J Exp Med.</italic></source><year>2011</year>;<volume>208</volume>(<issue>10</issue>):<fpage>2083</fpage>–<lpage>2098</lpage>.
<pub-id pub-id-type="doi">10.1084/jem.20101568</pub-id><!--<pub-id pub-id-type="pmcid">3182056</pub-id>--><?supplied-pmid 21911422?><pub-id pub-id-type="pmid">21911422</pub-id></mixed-citation>
    </ref>
    <ref id="ref-18">
      <label>18</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciancanelli</surname><given-names>MJ</given-names></name><name><surname>Huang</surname><given-names>SX</given-names></name><name><surname>Luthra</surname><given-names>P</given-names></name><etal/></person-group>:
<article-title>Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency.</article-title><source><italic toggle="yes">Science.</italic></source><year>2015</year>;<volume>348</volume>(<issue>6233</issue>):<fpage>448</fpage>–<lpage>53</lpage>.
<pub-id pub-id-type="doi">10.1126/science.aaa1578</pub-id><!--<pub-id pub-id-type="pmcid">4431581</pub-id>--><?supplied-pmid 25814066?><pub-id pub-id-type="pmid">25814066</pub-id></mixed-citation>
    </ref>
    <ref id="ref-19">
      <label>19</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speake</surname><given-names>C</given-names></name><name><surname>Presnell</surname><given-names>S</given-names></name><name><surname>Domico</surname><given-names>K</given-names></name><etal/></person-group>:
<article-title>An interactive web application for the dissemination of human systems immunology data.</article-title><source><italic toggle="yes">J Transl Med.</italic></source><year>2015</year>;<volume>13</volume>:<fpage>196</fpage>.
<pub-id pub-id-type="doi">10.1186/s12967-015-0541-x</pub-id><!--<pub-id pub-id-type="pmcid">4474328</pub-id>--><?supplied-pmid 26088622?><pub-id pub-id-type="pmid">26088622</pub-id></mixed-citation>
    </ref>
    <ref id="ref-20">
      <label>20</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berglund</surname><given-names>LJ</given-names></name><name><surname>Avery</surname><given-names>DT</given-names></name><name><surname>Ma</surname><given-names>CS</given-names></name><etal/></person-group>:
<article-title>IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts.</article-title><source><italic toggle="yes">Blood.</italic></source><year>2013</year>;<volume>122</volume>(<issue>24</issue>):<fpage>3940</fpage>–<lpage>50</lpage>.
<pub-id pub-id-type="doi">10.1182/blood-2013-06-506865</pub-id><!--<pub-id pub-id-type="pmcid">3854113</pub-id>--><?supplied-pmid 24159173?><pub-id pub-id-type="pmid">24159173</pub-id></mixed-citation>
    </ref>
    <ref id="ref-21">
      <label>21</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lafaille</surname><given-names>FG</given-names></name><name><surname>Pessach</surname><given-names>IM</given-names></name><name><surname>Zhang</surname><given-names>SY</given-names></name><etal/></person-group>:
<article-title>Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells.</article-title><source><italic toggle="yes">Nature.</italic></source><year>2012</year>;<volume>491</volume>(<issue>7426</issue>):<fpage>769</fpage>–<lpage>73</lpage>.
<pub-id pub-id-type="doi">10.1038/nature11583</pub-id><!--<pub-id pub-id-type="pmcid">3527075</pub-id>--><?supplied-pmid 23103873?><pub-id pub-id-type="pmid">23103873</pub-id></mixed-citation>
    </ref>
    <ref id="ref-22">
      <label>22</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boisson</surname><given-names>B</given-names></name><name><surname>Laplantine</surname><given-names>E</given-names></name><name><surname>Prando</surname><given-names>C</given-names></name><etal/></person-group>:
<article-title>Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency.</article-title><source><italic toggle="yes">Nat Immunol.</italic></source><year>2012</year>;<volume>13</volume>(<issue>12</issue>):<fpage>1178</fpage>–<lpage>86</lpage>.
<pub-id pub-id-type="doi">10.1038/ni.2457</pub-id><!--<pub-id pub-id-type="pmcid">3514453</pub-id>--><?supplied-pmid 23104095?><pub-id pub-id-type="pmid">23104095</pub-id></mixed-citation>
    </ref>
    <ref id="ref-23">
      <label>23</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morimoto</surname><given-names>M</given-names></name><name><surname>Myung</surname><given-names>C</given-names></name><name><surname>Beirnes</surname><given-names>K</given-names></name><etal/></person-group>:
<article-title>Increased Wnt and Notch signaling: a clue to the renal disease in Schimke immuno-osseous dysplasia?</article-title><source><italic toggle="yes">Orphanet J Rare Dis.</italic></source><year>2016</year>;<volume>11</volume>(<issue>1</issue>):<fpage>149</fpage>.
<pub-id pub-id-type="doi">10.1186/s13023-016-0519-7</pub-id><!--<pub-id pub-id-type="pmcid">5097426</pub-id>--><?supplied-pmid 27816064?><pub-id pub-id-type="pmid">27816064</pub-id></mixed-citation>
    </ref>
    <ref id="ref-24">
      <label>24</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Della Mina</surname><given-names>E</given-names></name><name><surname>Borghesi</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><etal/></person-group>:
<article-title>Inherited human IRAK-1 deficiency selectively impairs TLR signaling in fibroblasts.</article-title><source><italic toggle="yes">Proc Natl Acad Sci U S A.</italic></source><year>2017</year>;<volume>114</volume>(<issue>4</issue>):<fpage>E514</fpage>–<lpage>E523</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.1620139114</pub-id><!--<pub-id pub-id-type="pmcid">5278481</pub-id>--><?supplied-pmid 28069966?><pub-id pub-id-type="pmid">28069966</pub-id></mixed-citation>
    </ref>
    <ref id="ref-25">
      <label>25</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Munagala</surname><given-names>I</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><etal/></person-group>:
<article-title>Interferon Signature in the Blood in Inflammatory Common Variable Immune Deficiency.</article-title><source><italic toggle="yes">PLoS One.</italic></source><year>2013</year>;<volume>8</volume>(<issue>9</issue>):<fpage>e74893</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0074893</pub-id><!--<pub-id pub-id-type="pmcid">3775732</pub-id>--><?supplied-pmid 24069364?><pub-id pub-id-type="pmid">24069364</pub-id></mixed-citation>
    </ref>
    <ref id="ref-26">
      <label>26</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isnardi</surname><given-names>I</given-names></name><name><surname>Ng</surname><given-names>YS</given-names></name><name><surname>Srdanovic</surname><given-names>I</given-names></name><etal/></person-group>:
<article-title>IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans.</article-title><source><italic toggle="yes">Immunity.</italic></source><year>2008</year>;<volume>29</volume>(<issue>5</issue>):<fpage>746</fpage>–<lpage>57</lpage>.
<pub-id pub-id-type="doi">10.1016/j.immuni.2008.09.015</pub-id><!--<pub-id pub-id-type="pmcid">2666307</pub-id>--><?supplied-pmid 19006693?><pub-id pub-id-type="pmid">19006693</pub-id></mixed-citation>
    </ref>
    <ref id="ref-27">
      <label>27</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohn</surname><given-names>G</given-names></name><name><surname>Allroth</surname><given-names>A</given-names></name><name><surname>Brandes</surname><given-names>G</given-names></name><etal/></person-group>:
<article-title>A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14.</article-title><source><italic toggle="yes">Nat Med.</italic></source><year>2007</year>;<volume>13</volume>(<issue>1</issue>):<fpage>38</fpage>–<lpage>45</lpage>.
<pub-id pub-id-type="doi">10.1038/nm1528</pub-id><?supplied-pmid 17195838?><pub-id pub-id-type="pmid">17195838</pub-id></mixed-citation>
    </ref>
    <ref id="ref-28">
      <label>28</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>M</given-names></name><name><surname>Boughorbel</surname><given-names>S</given-names></name><name><surname>Presnell</surname><given-names>S</given-names></name><etal/></person-group>:
<article-title>A curated transcriptome dataset collection to investigate the functional programming of human hematopoietic cells in early life [version 1; referees: 2 approved].</article-title><source><italic toggle="yes">F1000Res.</italic></source><year>2016</year>;<volume>5</volume>:<fpage>414</fpage>.
<pub-id pub-id-type="doi">10.12688/f1000research.8375.1</pub-id><!--<pub-id pub-id-type="pmcid">4916988</pub-id>--><?supplied-pmid 27347375?><pub-id pub-id-type="pmid">27347375</pub-id></mixed-citation>
    </ref>
    <ref id="ref-29">
      <label>29</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marr</surname><given-names>AK</given-names></name><name><surname>Boughorbel</surname><given-names>S</given-names></name><name><surname>Presnell</surname><given-names>S</given-names></name><etal/></person-group>:
<article-title>A curated transcriptome dataset collection to investigate the development and differentiation of the human placenta and its associated pathologies [version 2; referees: 2 approved].</article-title><source><italic toggle="yes">F1000Res.</italic></source><year>2016</year>;<volume>5</volume>:<fpage>305</fpage>.
<pub-id pub-id-type="doi">10.12688/f1000research.8210.2</pub-id><!--<pub-id pub-id-type="pmcid">4897750</pub-id>--><?supplied-pmid 27303626?><pub-id pub-id-type="pmid">27303626</pub-id></mixed-citation>
    </ref>
    <ref id="ref-30">
      <label>30</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinchai</surname><given-names>D</given-names></name><name><surname>Boughorbel</surname><given-names>S</given-names></name><name><surname>Presnell</surname><given-names>S</given-names></name><etal/></person-group>:
<article-title>A curated compendium of monocyte transcriptome datasets of relevance to human monocyte immunobiology research [version 2; referees: 2 approved].</article-title><source><italic toggle="yes">F1000Res.</italic></source><year>2016</year>;<volume>5</volume>:<fpage>291</fpage>.
<pub-id pub-id-type="doi">10.12688/f1000research.8182.2</pub-id><!--<pub-id pub-id-type="pmcid">4856112</pub-id>--><?supplied-pmid 27158452?><pub-id pub-id-type="pmid">27158452</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<sub-article id="report53217" article-type="peer-review">
  <front-stub>
    <article-id pub-id-type="doi">10.5256/f1000research.22465.r53217</article-id>
    <title-group>
      <article-title>Reviewer response for version 2</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Ziegler</surname>
          <given-names>John B.</given-names>
        </name>
        <xref ref-type="aff" rid="r53217a1">1</xref>
        <xref ref-type="aff" rid="r53217a2">2</xref>
        <role>Referee</role>
        <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5257-3113</contrib-id>
      </contrib>
      <aff id="r53217a1"><label>1</label>School of Women's &amp; Children's Health, University of New South Wales, Sydney, NSW, Australia</aff>
      <aff id="r53217a2"><label>2</label>Department of Immunology &amp; infectious Diseases, Sydney Children's Hospital, Sydney, Australia</aff>
    </contrib-group>
    <author-notes>
      <fn fn-type="COI-statement">
        <p><bold>Competing interests: </bold>No competing interests were disclosed.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="epub">
      <day>17</day>
      <month>9</month>
      <year>2019</year>
    </pub-date>
    <permissions>
      <copyright-statement>Copyright: © 2019 Ziegler JB</copyright-statement>
      <copyright-year>2019</copyright-year>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <related-article related-article-type="peer-reviewed-article" id="d35e3106" ext-link-type="doi" xlink:href="10.12688/f1000research.18048.2">Version 2</related-article>
    <custom-meta-group>
      <custom-meta>
        <meta-name>recommendation</meta-name>
        <meta-value>approve</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>All is now in order with significant improvements in response to peer review.</p>
    <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
  </body>
</sub-article>
<sub-article id="report53218" article-type="peer-review">
  <front-stub>
    <article-id pub-id-type="doi">10.5256/f1000research.22465.r53218</article-id>
    <title-group>
      <article-title>Reviewer response for version 2</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>De Meulder</surname>
          <given-names>Bertrand</given-names>
        </name>
        <xref ref-type="aff" rid="r53218a1">1</xref>
        <xref ref-type="aff" rid="r53218a2">2</xref>
        <role>Referee</role>
        <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2108-7657</contrib-id>
      </contrib>
      <aff id="r53218a1"><label>1</label>European Institute for Systems Biology &amp; Medicine, Université de Lyon, Lyon, France</aff>
      <aff id="r53218a2"><label>2</label>Association EISBM, Vourles, France</aff>
    </contrib-group>
    <author-notes>
      <fn fn-type="COI-statement">
        <p><bold>Competing interests: </bold>No competing interests were disclosed.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="epub">
      <day>9</day>
      <month>9</month>
      <year>2019</year>
    </pub-date>
    <permissions>
      <copyright-statement>Copyright: © 2019 De Meulder B</copyright-statement>
      <copyright-year>2019</copyright-year>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <related-article related-article-type="peer-reviewed-article" id="d35e3172" ext-link-type="doi" xlink:href="10.12688/f1000research.18048.2">Version 2</related-article>
    <custom-meta-group>
      <custom-meta>
        <meta-name>recommendation</meta-name>
        <meta-value>approve</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>I feel my comments have been taken into account and hence approve the indexing of this manuscript.</p>
    <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
  </body>
</sub-article>
<sub-article id="report45485" article-type="peer-review">
  <front-stub>
    <article-id pub-id-type="doi">10.5256/f1000research.19737.r45485</article-id>
    <title-group>
      <article-title>Reviewer response for version 1</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Ziegler</surname>
          <given-names>John B.</given-names>
        </name>
        <xref ref-type="aff" rid="r45485a1">1</xref>
        <xref ref-type="aff" rid="r45485a2">2</xref>
        <role>Referee</role>
        <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5257-3113</contrib-id>
      </contrib>
      <aff id="r45485a1"><label>1</label>School of Women's &amp; Children's Health, University of New South Wales, Sydney, NSW, Australia</aff>
      <aff id="r45485a2"><label>2</label>Department of Immunology &amp; infectious Diseases, Sydney Children's Hospital, Sydney, Australia</aff>
    </contrib-group>
    <author-notes>
      <fn fn-type="COI-statement">
        <p><bold>Competing interests: </bold>No competing interests were disclosed.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="epub">
      <day>28</day>
      <month>3</month>
      <year>2019</year>
    </pub-date>
    <permissions>
      <copyright-statement>Copyright: © 2019 Ziegler JB</copyright-statement>
      <copyright-year>2019</copyright-year>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <related-article related-article-type="peer-reviewed-article" id="d35e3238" ext-link-type="doi" xlink:href="10.12688/f1000research.18048.1">Version 1</related-article>
    <custom-meta-group>
      <custom-meta>
        <meta-name>recommendation</meta-name>
        <meta-value>approve-with-reservations</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>This is a useful tool to examine publicly available gene transcript data.</p>
    <p> The paper would be more useful if it included more detailed instructions for its use, perhaps including screenshots to illustrate the text.</p>
    <p> The location of the PubMed link of each sample wasn’t immediately obvious to this reader. I now realise it is accessed by clicking a part of the PubMed.gov icon.</p>
    <p> The meaning of the term “ranking” becomes apparent with use but it would not be burdensome to more experienced readers to have it defined or explained.</p>
    <p> The acronym for induced pluripotent stem cells (iPS) should be defined with first use.</p>
    <p> The sample set “Whole Blood Transcriptional Modules generated on Illumina Hu-6 V2 Beadchips. GSE29536” is listed with the disease category “Immunodeficiencies” but the data presented appears to include none from immunodeficiency settings. I see transcripts from infections, SLE, diabetes, Still’s disease. I can’t get more detail of the study because the PubMed link is wrong. The link provided is
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/24069364">https://www.ncbi.nlm.nih.gov/pubmed/24069364</ext-link> which is actually the link for other listed samples (
<ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000043">GSE51404</ext-link> and
<ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000043">GSE51405</ext-link>). I haven’t verified all links in the table.</p>
    <p> If improvements such as those above were addressed I believe the paper would be very useful to those conducting immunological research.</p>
    <p> If improvements such as those above were addressed I believe the paper would be very useful to those conducting immunological research.</p>
    <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
  </body>
  <sub-article id="comment4860" article-type="response">
    <front-stub>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bougarn</surname>
            <given-names>Salim</given-names>
          </name>
          <aff>Sidra Medicine, Qatar</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Competing interests: </bold>No competing interests were disclosed.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>8</month>
        <year>2019</year>
      </pub-date>
    </front-stub>
    <body>
      <p>Dear Dr. Ziegler,</p>
      <p>We are  thankful to Dr. Ziegler  for his positive feed back regarding our manuscript and for the careful revision. We respond to the specific comments and describe the introduced changes to the new version below in the text and in bold.  </p>
      <p>The paper would be more useful if it included more detailed instructions for its use, perhaps including screenshots to illustrate the text.</p>
      <p>
        <bold>We have updated a link to the tutorial (http://pid.gxbsidra.org/dm3/tutorials.gsp) as well as a reference to a paper describing [Speake et. al) on how to use GXB with detailed instructions including screenshots.</bold>
      </p>
      <p>The location of the PubMed link of each sample wasn’t immediately obvious to this reader. I now realise it is accessed by clicking a part of the PubMed.gov icon.</p>
      <p>The meaning of the term “ranking” becomes apparent with use but it would not be burdensome to more experienced readers to have it defined or explained.</p>
      <p>
        <bold>The ranking was explained in material and methods section in the paper</bold>
      </p>
      <p>The acronym for induced pluripotent stem cells (iPS) should be defined with first use.</p>
      <p>
        <bold>We have added to the paper the definition of iPS.</bold>
      </p>
      <p>The sample set “Whole Blood Transcriptional Modules generated on Illumina Hu-6 V2 Beadchips. GSE29536” is listed with the disease category “Immunodeficiencies” but the data presented appears to include none from immunodeficiency settings. I see transcripts from infections, SLE, diabetes, Still’s disease. I can’t get more detail of the study because the PubMed link is wrong. The link provided is
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/24069364">https://www.ncbi.nlm.nih.gov/pubmed/24069364</ext-link> which is actually the link for other listed samples (
<ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000043">GSE51404</ext-link> and
<ext-link ext-link-type="uri" xlink:href="http://pid.gxbsidra.org/dm3/geneBrowser/show/4000043">GSE51405</ext-link>). I haven’t verified all links in the table.</p>
      <p>
        <bold>We have removed the GSE29536 from the instance and the datanote and modified the total number of datasets retrieved and loaded into GXB. But also, we modified the table 1 and figure 1.</bold>
      </p>
      <p>
        <bold>We have checked and verified all PubMed links in other datasets.  </bold>
      </p>
      <p>If improvements such as those above were addressed I believe the paper would be very useful to those conducting immunological research.</p>
      <p>
        <bold>The requested improvements have been incorporated in the paper.</bold>
      </p>
      <p>
        <bold> Please note that other minor modification updates were done on the manuscript, such as the total number of datasets found in the GEO database using the criteria mentioned in the paper. </bold>
      </p>
    </body>
  </sub-article>
</sub-article>
<sub-article id="report45968" article-type="peer-review">
  <front-stub>
    <article-id pub-id-type="doi">10.5256/f1000research.19737.r45968</article-id>
    <title-group>
      <article-title>Reviewer response for version 1</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>De Meulder</surname>
          <given-names>Bertrand</given-names>
        </name>
        <xref ref-type="aff" rid="r45968a1">1</xref>
        <xref ref-type="aff" rid="r45968a2">2</xref>
        <role>Referee</role>
        <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2108-7657</contrib-id>
      </contrib>
      <aff id="r45968a1"><label>1</label>European Institute for Systems Biology &amp; Medicine, Université de Lyon, Lyon, France</aff>
      <aff id="r45968a2"><label>2</label>Association EISBM, Vourles, France</aff>
    </contrib-group>
    <author-notes>
      <fn fn-type="COI-statement">
        <p><bold>Competing interests: </bold>No competing interests were disclosed.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="epub">
      <day>21</day>
      <month>3</month>
      <year>2019</year>
    </pub-date>
    <permissions>
      <copyright-statement>Copyright: © 2019 De Meulder B</copyright-statement>
      <copyright-year>2019</copyright-year>
      <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <related-article related-article-type="peer-reviewed-article" id="d35e3414" ext-link-type="doi" xlink:href="10.12688/f1000research.18048.1">Version 1</related-article>
    <custom-meta-group>
      <custom-meta>
        <meta-name>recommendation</meta-name>
        <meta-value>approve-with-reservations</meta-value>
      </custom-meta>
    </custom-meta-group>
  </front-stub>
  <body>
    <p>This article presents a tool to gather and make preliminary analyses on a set of curated sequencing datasets related to primary immunodeficiencies. </p>
    <p> Regarding replication, I could not reproduce the list of datasets with the criteria that are mentioned in the text. I would have to believe that the authors are indeed reporting their results, and that the manual curation of the dataset list was accurate.  </p>
    <p> The tool that is presented has a number of issues:
<list list-type="bullet"><list-item><p>The list of datasets is rather small, and the authors do not mention whether they plan on adding datasets to the list,</p></list-item><list-item><p>The tutorials on how to use the tools are only available to registered users, and I could not find how to register</p></list-item><list-item><p>Graphical issues are present when displaying the charts, both in-tool and in png images.</p></list-item></list>
</p>
    <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
  </body>
  <sub-article id="comment4859" article-type="response">
    <front-stub>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bougarn</surname>
            <given-names>Salim</given-names>
          </name>
          <aff>Sidra Medicine, Qatar</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Competing interests: </bold>No competing interests were disclosed.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>8</month>
        <year>2019</year>
      </pub-date>
    </front-stub>
    <body>
      <p>Dear Bertrand, </p>
      <p> We are  thankful to Dr. De Meulder for his positive feed back regarding our manuscript and for the careful revision. We respond to the specific comments and describe the introduced changes to the new version below in the text and in bold.  </p>
      <p> Regarding replication, I could not reproduce the list of datasets with the criteria that are mentioned in the text. I would have to believe that the authors are indeed reporting their results, and that the manual curation of the dataset list was accurate.  </p>
      <p>
        <bold>This is not related to GXB but on the pubmed search criteria. Also, please note that the GEO database is growing over time and for your attention the query was run in date 2017-2-1. I have updated in the paper the total number of datasets found in the GEO database using the criteria mentioned in the paper.</bold>
      </p>
      <p> The tool that is presented has a number of issues:
<list list-type="bullet"><list-item><p>The list of datasets is rather small, and the authors do not mention whether they plan on adding datasets to the list,</p></list-item></list>
<bold>The curation of the datasets requires substantial effort so we decide to freeze the addition of dataset for this version. We are planning to update the datasets in a future version of the paper. A sentence was added to the material and method in the paper.</bold>
<list list-type="bullet"><list-item><p>The tutorials on how to use the tools are only available to registered users, and I could not find how to register</p></list-item></list>
<bold>The tutorial is available also for non registered user via the following link: http://pid.gxbsidra.org/dm3/tutorials.gsp. The link in the paper was modified. </bold>
<list list-type="bullet"><list-item><p>Graphical issues are present when displaying the charts, both in-tool and in png images.</p></list-item></list>
<bold>It is not clear what graphical issue exactly you encounter. It is possible to hide info panel information to resize the graphs and get a better visualization.</bold>
</p>
      <p>
        <bold/>
      </p>
      <p>
        <bold> Please note that the GSE29536 datasets was removed from the instance and the datanote (Table 1). The figure 1 was slightly modified.  Also, the total number of datasets retrieved, selected and loaded to GXB was modified. </bold>
      </p>
    </body>
  </sub-article>
</sub-article>
